ACCESSION: MSBNK-SMB_Measured-HSA001P0183003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 99
COMMENT: RAW_SPEC {'BLK01_7': {'bp': 858050.0, 'sum': 2400130.0}, 'BLK01_322': {'bp': 853992.0, 'sum': 2407521.0}, 'BLK01_512': {'bp': 851185.0, 'sum': 2416914.0}, 'BLK01_70': {'bp': 844205.0, 'sum': 2400970.0}, 'BLK01_134': {'bp': 842827.0, 'sum': 2427144.0}, 'BLK01_449': {'bp': 811553.0, 'sum': 2246858.0}, 'BLK01_197': {'bp': 804169.0, 'sum': 2283199.0}, 'BLK01_259': {'bp': 800312.0, 'sum': 2246461.0}, 'ProcedureBlank_267': {'bp': 488336.0, 'sum': 1459456.0}, 'ProcedureBlank_182': {'bp': 486748.0, 'sum': 1503617.0}, '8_posi_60': {'bp': 476048.0, 'sum': 1483120.0}, '2_posi_300': {'bp': 467656.0, 'sum': 1405894.0}, '1_posi_59': {'bp': 460983.0, 'sum': 1491086.0}, '1_posi_733': {'bp': 457789.0, 'sum': 1452948.0}, 'ProcedureBlank_78': {'bp': 454816.0, 'sum': 1382787.0}, '12_posi_60': {'bp': 450312.0, 'sum': 1469339.0}, '2_posi_61': {'bp': 449494.0, 'sum': 1396646.0}, 'BLK02_62': {'bp': 445698.0, 'sum': 1458136.0}, '1_posi_136': {'bp': 445034.0, 'sum': 1414024.0}, '3_posi_79': {'bp': 437695.0, 'sum': 1402187.0}, '3_posi_184': {'bp': 433380.0, 'sum': 1443868.0}, '10_posi_166': {'bp': 423794.0, 'sum': 1398169.0}, '7_posi_62': {'bp': 423067.0, 'sum': 1332356.0}, '12_posi_229': {'bp': 422903.0, 'sum': 1340501.0}, '17_posi_59': {'bp': 422646.0, 'sum': 1325713.0}, '4_posi_60': {'bp': 419503.0, 'sum': 1287545.0}, '13_posi_394': {'bp': 419132.0, 'sum': 1322506.0}, 'ProcedureBlank_533': {'bp': 418850.0, 'sum': 1337984.0}, '4_posi_164': {'bp': 418616.0, 'sum': 1320500.0}, '3_posi_356': {'bp': 416903.0, 'sum': 1272316.0}, '15_posi_29': {'bp': 416739.0, 'sum': 1406184.0}, '14_posi_26': {'bp': 414933.0, 'sum': 1360246.0}, '8_posi_272': {'bp': 413987.0, 'sum': 1336456.0}, '5_posi_737': {'bp': 413216.0, 'sum': 1394832.0}, '2_posi_164': {'bp': 412256.0, 'sum': 1340356.0}, '4_posi_354': {'bp': 412145.0, 'sum': 1276219.0}, '10_posi_232': {'bp': 410294.0, 'sum': 1317209.0}, '3_posi_260': {'bp': 409269.0, 'sum': 1328549.0}, '1_posi_396': {'bp': 409035.0, 'sum': 1297983.0}, '13_posi_172': {'bp': 408370.0, 'sum': 1332158.0}, '2_posi_405': {'bp': 407031.0, 'sum': 1277830.0}, '1_posi_276': {'bp': 405707.0, 'sum': 1276914.0}, '6_posi_556': {'bp': 402983.0, 'sum': 1217083.0}, '11_posi_76': {'bp': 402128.0, 'sum': 1203460.0}, '6_posi_60': {'bp': 402068.0, 'sum': 1310059.0}, '11_posi_164': {'bp': 402048.0, 'sum': 1309697.0}, '6_posi_398': {'bp': 399735.0, 'sum': 1243789.0}, '15_posi_386': {'bp': 399179.0, 'sum': 1235797.0}, '6_posi_208': {'bp': 398858.0, 'sum': 1286362.0}, '13_posi_260': {'bp': 396210.0, 'sum': 1247709.0}, '17_posi_163': {'bp': 394694.0, 'sum': 1286404.0}, '7_posi_266': {'bp': 391982.0, 'sum': 1242602.0}, '1_posi_207': {'bp': 391929.0, 'sum': 1230481.0}, '2_posi_711': {'bp': 389546.0, 'sum': 1162245.0}, '8_posi_159': {'bp': 380012.0, 'sum': 1280899.0}, '18_posi_106': {'bp': 378971.0, 'sum': 1245592.0}, '7_posi_199': {'bp': 378514.0, 'sum': 1288971.0}, 'BLK02_636': {'bp': 376196.0, 'sum': 1261679.0}, '7_posi_355': {'bp': 375852.0, 'sum': 1219645.0}, 'ProcedureBlank_701': {'bp': 373917.0, 'sum': 1164947.0}, '5_posi_326': {'bp': 372234.0, 'sum': 1207517.0}, '15_posi_323': {'bp': 370035.0, 'sum': 1205792.0}, '15_posi_453': {'bp': 368866.0, 'sum': 1322278.0}, '6_posi_291': {'bp': 366776.0, 'sum': 1164955.0}, '4_posi_272': {'bp': 366711.0, 'sum': 1169177.0}, '9_posi_557': {'bp': 365620.0, 'sum': 1229055.0}, '14_posi_209': {'bp': 365094.0, 'sum': 1193105.0}, '5_posi_75': {'bp': 363157.0, 'sum': 1172889.0}, '18_posi_46': {'bp': 360819.0, 'sum': 1252690.0}, '5_posi_251': {'bp': 356655.0, 'sum': 1157334.0}, '5_posi_531': {'bp': 356082.0, 'sum': 1206509.0}, '9_posi_143': {'bp': 354467.0, 'sum': 1161531.0}, '9_posi_276': {'bp': 353621.0, 'sum': 1127043.0}, '9_posi_386': {'bp': 350375.0, 'sum': 1124135.0}, '8_posi_709': {'bp': 348476.0, 'sum': 1149675.0}, '16_posi_164': {'bp': 338094.0, 'sum': 1131984.0}, '6_posi_638': {'bp': 337406.0, 'sum': 1055897.0}, '16_posi_46': {'bp': 332161.0, 'sum': 1099568.0}, '15_posi_701': {'bp': 329921.0, 'sum': 1053352.0}, '19_posi_295': {'bp': 328360.0, 'sum': 1043176.0}, '14_posi_640': {'bp': 327335.0, 'sum': 1074067.0}, '4_posi_690': {'bp': 326514.0, 'sum': 1007462.0}, '14_posi_703': {'bp': 325019.0, 'sum': 1086063.0}, '6_posi_704': {'bp': 324617.0, 'sum': 1077129.0}, '18_posi_360': {'bp': 319613.0, 'sum': 1105269.0}, '5_posi_398': {'bp': 317726.0, 'sum': 996504.0}, '5_posi_613': {'bp': 315594.0, 'sum': 1021456.0}, '7_posi_655': {'bp': 307535.0, 'sum': 1029113.0}, '9_posi_657': {'bp': 302872.0, 'sum': 993602.0}, '19_posi_232': {'bp': 301669.0, 'sum': 1040249.0}, '17_posi_671': {'bp': 297456.0, 'sum': 982597.0}, '19_posi_48': {'bp': 294983.0, 'sum': 1001172.0}, '15_posi_638': {'bp': 292276.0, 'sum': 995244.0}, '16_posi_271': {'bp': 291710.0, 'sum': 965556.0}, '5_posi_676': {'bp': 288733.0, 'sum': 990096.0}, '19_posi_170': {'bp': 277661.0, 'sum': 931269.0}, '19_posi_388': {'bp': 271320.0, 'sum': 965176.0}, '18_posi_423': {'bp': 269130.0, 'sum': 863962.0}, '19_posi_515': {'bp': 259323.0, 'sum': 998638.0}}
COMMENT: RETENTION_TIME_STDEV 0.435
COMMENT: PRECURSOR_M/Z_RAW 183.123749
COMMENT: PRECURSOR_M/Z_STDEV 0.000073
COMMENT: PRECURSOR_IN_MS1 mz 183.124063; int 182.243; delta(ppm) 1.041279
COMMENT: PROPOSED_CHARGE_STATE +1; mz 184.127282; int 14.093; cor 0.811
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+CH3OH+H; mz 215.150297; int 28.933; cor 0.661
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 224.150617; int 26.605; cor 0.609
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 224.150617; int 26.605; cor 0.609
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+H; mz 142.097543; int 993.781; cor 0.707
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 224.150617; int 26.605; cor 0.609
COMMENT: PROPOSED_ION_FORM M+ACN+Na; M+Na; mz 142.097543; int 993.781; cor 0.707
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+ACN+H; mz 142.097543; int 993.781; cor 0.707
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.137; C8H14N4O; [M+H]+; delta(ppm) 0.137275
COMMENT: PROPOSED_MF SevenGoldenRules 0.191; C6H11N3O; [M+ACN+H]+; delta(ppm) 0.191367
COMMENT: PROPOSED_MF SevenGoldenRules 0.290; C4H8N2O; [M+2ACN+H]+; delta(ppm) 0.289815
COMMENT: PROPOSED_MF MS-FINDER 3.302; C6H11N3O; [M+ACN+H]+; delta(ppm) 89372.095774
COMMENT: PROPOSED_MF MS-FINDER 3.211; C8H14N4O; [M+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF MS-FINDER 3.057; C4H8N2O; [M+2ACN+H]+; delta(ppm) 441081.911237
COMMENT: PROPOSED_MF SIRIUS5_Sirius 54.166; C8H14N4O; [M+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS5_Sirius 54.166; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS5_Sirius 45.466; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H14N4O; [M+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS6_Sirius 94.980; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS6_Sirius 94.980; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS6_Sirius 94.980; C8H14N4O; [M+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS6_Sirius 84.112; C5H15FN4O2; [M+H]+; delta(ppm) -6.106118
COMMENT: PROPOSED_MF SIRIUS6_Sirius 65.830; C8H18NO2; [M+Na]+; delta(ppm) 51613.499534
COMMENT: PROPOSED_MF SIRIUS6_Sirius 65.830; C6H15O2; [M+C2H3N+Na]+; delta(ppm) 51613.499534
COMMENT: PROPOSED_MF SIRIUS6_Sirius 40.768; C4H17N5OP; [M+H]+; delta(ppm) -1.554317
COMMENT: PROPOSED_MF SIRIUS6_Sirius 37.097; C8H13O2; [M+C2H3N+H]+; delta(ppm) -7.198312
COMMENT: PROPOSED_MF SIRIUS6_Sirius 37.097; C10H16NO2; [M+H]+; delta(ppm) -7.198312
COMMENT: PROPOSED_MF SIRIUS6_Sirius 34.504; C4H9N6; [M+C2H3N+H]+; delta(ppm) 7.465669
COMMENT: PROPOSED_MF SIRIUS6_Sirius 34.504; C2H6N5; [M+C4H6N2+H]+; delta(ppm) 7.465669
COMMENT: PROPOSED_MF SIRIUS6_Sirius 34.504; C6H12N7; [M+H]+; delta(ppm) 7.465669
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.021; C8H15F3N; [M+H]+; delta(ppm) 6.154784
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.643; C2H15N8P; [M+H]+; delta(ppm) 5.777703
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H18NO2; [M+Na]+; delta(ppm) 51613.499534
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H14N4O; [M+H]+; delta(ppm) 0.133625
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H15O2; [M+C2H3N+Na]+; delta(ppm) 51613.499534
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.771; CNQSLMMJABEBDE-UHFFFAOYNA-N; [M+H]+; NC(CCC1=CN=CN1)CC(O)=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.624; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; CCCC1=NN(C)C(C(N)=O)=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.470; MIWXKXSYVQATIB-UHFFFAOYSA-N; [M+H]+; N=1OC(=NC1C)C2N(C)CC(N)C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.463; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; NCCC(=O)NCCC1=CN=CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.201; ZJFRMJHBYDBUGG-UHFFFAOYSA-N; [M+H]+; CC(C)(C)C1=CC(=NN1)C(=O)NN
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.687; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+ACN+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.356; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.198; MIWXKXSYVQATIB-UHFFFAOYSA-N; [M+H]+; CNP0438350
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.151; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; 4-amino-1-methyl-3-propylpyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.050; IMAGWKUTFZRWSB-HYXAFXHYSA-N; [M+2ACN+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.019; CNQSLMMJABEBDE-UHFFFAOYNA-N; [M+H]+; 3-amino-5-(1H-imidazol-5-yl)pentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.915; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+2ACN+H]+; N-Nitroso-pyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.884; ZJFRMJHBYDBUGG-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-pyrazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.845; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+2ACN+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.726; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+2ACN+H]+; perhydropyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+ACN+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+2ACN+H]+; perhydropyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.996; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+2ACN+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.975; IMAGWKUTFZRWSB-HYXAFXHYSA-N; [M+2ACN+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.807; MIWXKXSYVQATIB-UHFFFAOYSA-N; [M+H]+; CNP0438350
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.796; CNQSLMMJABEBDE-UHFFFAOYNA-N; [M+H]+; 3-amino-5-(1H-imidazol-5-yl)pentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.718; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; 4-amino-1-methyl-3-propylpyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.398; ZJFRMJHBYDBUGG-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-pyrazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.188; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+2ACN+H]+; N-Nitroso-pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.881; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+ACN+H]+; (2S)-2-amino-3-(1H-imidazol-5-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.185; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+2ACN+H]+; 1-nitrosopyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.073; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+2ACN+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.867; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+2ACN+H]+; 1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.735; IMAGWKUTFZRWSB-HWKANZROSA-N; [M+2ACN+H]+; N-[(E)-ethylideneamino]-N-methylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.440; DWEQVNFWAKJCEY-UHFFFAOYSA-N; [M+2ACN+H]+; 4-methylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.388; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-5-propylpyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.286; SINFFOPRQUJXEU-UHFFFAOYSA-N; [M+H]+; [1-(oxan-4-yl)pyrazol-3-yl]hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.275; OXTSWTYFSHETKF-UHFFFAOYSA-N; [M+H]+; 4-amino-N,2-diethylpyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; NMGPZPUIAUQPJA-UHFFFAOYSA-N; [M+ACN+H]+; [1-(2-aminoethyl)imidazol-4-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.192; USQBXXFEWJNNLW-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-piperidin-4-yl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.164; CIECLHRLHFXCEF-UHFFFAOYSA-N; [M+H]+; 6-ethyl-4-(propan-2-ylamino)-1H-1,3,5-triazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.158; OTXQUUARRHAWEI-UHFFFAOYSA-N; [M+H]+; 5-(1-methylpiperidin-3-yl)-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.150; QEHBKIRYKVJAAQ-UHFFFAOYSA-N; [M+H]+; (1-piperidin-3-yltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.144; KMUNXDCQPABTSC-UHFFFAOYSA-N; [M+H]+; N,4-diethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; IBYIOHMUWBIKCY-UHFFFAOYSA-N; [M+2ACN+H]+; N-methoxyazetidin-3-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; NPNNXLZXOYJJIV-UHFFFAOYSA-N; [M+H]+; [1-(oxan-4-yl)triazol-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.138; AFGWGIRVJYUUMY-UHFFFAOYSA-N; [M+H]+; 4-ethoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.131; APLFLTVZOUDTFG-UHFFFAOYSA-N; [M+H]+; 2-methyl-5-(oxan-4-yl)-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.122; RUOBZLJWEMZMRP-UHFFFAOYSA-N; [M+H]+; 2-(5-ethyl-1H-1,2,4-triazol-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.121; ASEMWMLOGSUFFL-UHFFFAOYSA-N; [M+ACN+H]+; 4-(2-aminoethyl)-3-methyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.118; OZVXTNDTEWDMGH-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-2-(1-methylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; IADZORFSCHBHIT-UHFFFAOYSA-N; [M+H]+; 3-methyl-4-(piperazin-1-ylmethyl)-1,2,5-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; QKHNQZUVFSQKFD-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-1-(1-methylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; NTVMXTHTWWIQBG-RNFRBKRXSA-N; [M+H]+; [(2R,3R)-2-(3-methyl-1H-1,2,4-triazol-5-yl)oxolan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.107; VCPRZYKEIPMTGJ-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-2-(1-methylpyrazol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.102; GTEXXCCAHDQARI-UHFFFAOYSA-N; [M+ACN+H]+; 1-amino-3-pyrazol-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.097; ZIWIZUNXJJKHPT-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-ylmethyl)piperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.094; YNDAMDVOGKACTP-UHFFFAOYSA-N; [M+2ACN+H]+; 3-aminopyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.091; IPLIJMUJLJBZDZ-UHFFFAOYSA-N; [M+ACN+H]+; 1-amino-3-imidazol-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.091; OZGHNDLEHPCVJQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-[4-(aminomethyl)pyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; JLNGHOSDXPAGAH-UHFFFAOYSA-N; [M+H]+; 4-(2-methyl-1,2,4-triazol-3-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; IVIGOAVSYQZAMR-UHFFFAOYSA-N; [M+H]+; 4-ethoxy-6-ethyl-N-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; FSRLLJVJCVKHQI-UHFFFAOYSA-N; [M+2ACN+H]+; 2-amino-3-hydroxy-2-methylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.082; RYFSOJLJCKEYBP-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1-aminoethyl)-1-methylpyrazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.076; OCEJLBIKKZYCBH-UHFFFAOYSA-N; [M+ACN+H]+; 1-(azetidin-3-yl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; DJPLUEGVLBIDTL-UHFFFAOYSA-N; [M+H]+; 4-[2-(dimethylamino)ethoxy]pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; DZQDVYLUCQEKGH-UHFFFAOYSA-N; [M+H]+; 4-methoxy-N-methyl-6-propyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.067; VEBSQSGLZKTWDS-BQBZGAKWSA-N; [M+H]+; N-methyl-1-[(2R,3R)-3-(1H-1,2,4-triazol-5-yl)oxolan-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.067; VQXSKHZPJBCSIZ-UHFFFAOYSA-N; [M+H]+; [3-(oxan-4-yl)-1H-1,2,4-triazol-5-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; AJOFBNLXIBLIPM-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-1-(1-methylimidazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; AKKYYGMQUOASSM-UHFFFAOYSA-N; [M+H]+; 5-methyl-N'-propan-2-yl-3H-pyrazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; RTGLANPQFMENLF-UHFFFAOYSA-N; [M+ACN+H]+; 2,5,6,7,8,8a-hexahydro-1H-imidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; IUBWCBLFKCGVGV-UHFFFAOYSA-N; [M+ACN+H]+; 2-(2-iminopyrrolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.042; AMRWCMHXSOIYPO-UHFFFAOYSA-N; [M+H]+; (5-piperidin-1-yl-1,3,4-oxadiazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; GNMSTEOVIGIVCR-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)-4,5,6,7-tetrahydrotriazolo[4,5-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.031; YUTDFIMDLUJOJK-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1,6-diazabicyclo[3.1.0]hexane-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; YHUCZYONIXCWBX-VQVTYTSYSA-N; [M+H]+; (1S,2S,4R)-2-(aminomethyl)-4-(1H-1,2,4-triazol-5-yl)cyclopentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; JTPZTKBRUCILQD-UHFFFAOYSA-N; [M+2ACN+H]+; 1-methylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.007; HKUSMMLJSPSXCL-UHFFFAOYSA-N; [M+ACN+H]+; 5-(3-aminopropyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.003; DHXLEVPVBKFTTR-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-5-pyrrolidin-2-yl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; MHFBJJKCSNFJEO-UHFFFAOYSA-N; [M+2ACN+H]+; 4,5-dihydro-1,2-oxazol-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.990; ZQIOGDSNYJYBTN-UHFFFAOYSA-N; [M+ACN+H]+; 3-(3-aminopyrazol-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; QJCMYUTUCCCBMY-UHFFFAOYSA-N; [M+ACN+H]+; 1-(3-aminopyrazol-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.973; VPJDULFXCAQHRC-UHFFFAOYSA-N; [M+2ACN+H]+; prop-2-enylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.970; YSSJLUSRTMOENN-UHFFFAOYSA-N; [M+H]+; 2-(methoxymethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; LGPFTDILVKZMRC-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-amino-4-methylpyrazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; QSRIMEJLSVTOCT-UHFFFAOYSA-N; [M+H]+; 4-[2-(1,2,4-triazol-1-yl)ethyl]morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; WRNALNJFNAAVKM-UHFFFAOYSA-N; [M+ACN+H]+; 2,5,7-triazaspiro[3.5]nonan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.945; NDFXVDCXWFVBHJ-UHFFFAOYSA-N; [M+H]+; 5-amino-1-tert-butylpyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; JIMSBKAHGYGPLD-UHFFFAOYSA-N; [M+2ACN+H]+; 4-aminopyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; VCSSOKBEBXXSDV-UHFFFAOYSA-N; [M+ACN+H]+; 5-methyl-2,5,7-triazaspiro[3.4]octan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.937; QYLRWTDPRQLHNV-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-methyldiazirin-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; YXAYZDNOWMFZLL-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(3-methyldiazirin-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; RPGPPCHMKDWLRT-UHFFFAOYSA-N; [M+2ACN+H]+; 2-amino-3-methoxypropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; REYGCAPKUGCICS-UHFFFAOYSA-N; [M+ACN+H]+; N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.918; YCXQDZIPLMEYGK-UHFFFAOYSA-N; [M+ACN+H]+; 2-[4-(methylamino)pyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; WBHVOQXHRCGQTP-UHFFFAOYSA-N; [M+ACN+H]+; 1-(3-ethyl-1,2,4-oxadiazol-5-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.912; KENWBTPXOITUBG-UHFFFAOYSA-N; [M+ACN+H]+; 3-(5-methyl-1,3,4-oxadiazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.912; ITDOBWWRWYKLQJ-UHFFFAOYSA-N; [M+ACN+H]+; 2,3,4,5-tetrahydropyridin-6-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; YEKKCMQUYOKDQD-UHFFFAOYSA-N; [M+ACN+H]+; 3-(3-methyl-1,2,4-oxadiazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.898; UAUSQEVPWPGBHG-UHFFFAOYSA-N; [M+2ACN+H]+; 3-aminobut-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; JKZWEWZMYSBQME-UHFFFAOYSA-N; [M+2ACN+H]+; 1-methylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.884; LHHBJUDYVRBYMB-UHFFFAOYSA-N; [M+ACN+H]+; 4-(aminomethyl)-2,5-dimethyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.867; ANQYOZSPKNDFPD-UHFFFAOYSA-N; [M+ACN+H]+; 2-(5-amino-3-methylpyrazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.867; AWDNCVJVQYZMTL-UHFFFAOYSA-N; [M+2ACN+H]+; N-methylaziridine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.862; YGJWTXRSKNXUAY-UHFFFAOYSA-N; [M+ACN+H]+; 5-methoxy-1,3-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; ZPUGMHPXVOHOAZ-UHFFFAOYSA-N; [M+ACN+H]+; (4-propyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.840; VQNRBFXKOWOEAC-UHFFFAOYSA-N; [M+ACN+H]+; 3-ethoxy-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; GQVNTZNZAGYMPA-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1,3-oxazolidin-2-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; AEBOLOPWWMZLBL-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-methyl-1,2,4-oxadiazol-5-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; WYVJDRGXWOXCCH-UHFFFAOYSA-N; [M+2ACN+H]+; 5-methylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; WJYMBVJBSFMDLE-HWKANZROSA-N; [M+2ACN+H]+; (2E)-2-(dimethylhydrazinylidene)acetaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.810; JANUDBLANRHSLI-UHFFFAOYSA-N; [M+ACN+H]+; 5-butyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.809; CIZWSGSWDKEWQD-UHFFFAOYSA-N; [M+ACN+H]+; 1-(2-methoxyethyl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.807; LURMHCWOXHNATM-UHFFFAOYSA-N; [M+ACN+H]+; 1-(2-methoxyethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; KJTMKVRSTYLHQN-UHFFFAOYSA-N; [M+ACN+H]+; 5-(methoxymethyl)-1-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.799; UXZYNPKVFMWVMT-UHFFFAOYSA-N; [M+ACN+H]+; 1-ethyl-3-methoxypyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.796; XIAOMTCYUPNRKB-UHFFFAOYSA-N; [M+ACN+H]+; (2-propan-2-yl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.795; VUQAASCCQZTWOG-UHFFFAOYSA-N; [M+ACN+H]+; 5-butan-2-yl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.768; WWGWIEDOVSRZPU-UHFFFAOYSA-N; [M+ACN+H]+; 2-tert-butyl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; KKCWBKUOPJMUQV-UHFFFAOYSA-N; [M+2ACN+H]+; azetidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; BIJFXVFSSOVINP-UHFFFAOYSA-N; [M+ACN+H]+; 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.760; XWBPAFFFOLTPTR-UHFFFAOYSA-N; [M+ACN+H]+; 3-(methoxymethyl)-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.755; MGDACALOFCAYGF-UHFFFAOYSA-N; [M+ACN+H]+; (3-methoxy-1-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.751; SRIBOFCAJXTSEL-UHFFFAOYSA-N; [M+ACN+H]+; 1-(1-methyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; VPOYXTRLFXNRJN-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-3-propan-2-yl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; IZYJJPFDVHGKAG-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1-methyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.723; VPVZSRIIAONGMU-UHFFFAOYSA-N; [M+2ACN+H]+; 5,6-dihydro-4H-1,3-oxazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.719; BMHYWTFRHPIOQM-UHFFFAOYSA-N; [M+ACN+H]+; 2-(2-oxopyrrolidin-1-yl)ethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -94.850; NQPJDJVGBDHCAD; [M+C4H6N2+H]+; Propyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -97.249; JTPZTKBRUCILQD; [M+C4H6N2+H]+; 1-Methyl-2-imidazolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -98.095; DWEQVNFWAKJCEY; [M+C4H6N2+H]+; 4-Methyl-2-imidazolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.102; YNDAMDVOGKACTP; [M+C4H6N2+H]+; Ambcb4019954
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -121.236; IWELDVXSEVIIGI; [M+C4H6N2+H]+; piperazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -126.341; WNYADZVDBIBLJJ; [M+C4H6N2+H]+; Nitrosopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -136.171; IMAGWKUTFZRWSB; [M+C4H6N2+H]+; Ethylidene gyromitrin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -142.796; ANRUJJLGVODXIK; [M+H]+; Carcinine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.932; WJYMBVJBSFMDLE; [M+C4H6N2+H]+; Glyoxal mono-dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.179; AWDNCVJVQYZMTL; [M+C4H6N2+H]+; N-Methylethyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.019; VPJDULFXCAQHRC; [M+C4H6N2+H]+; Allylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.124; KAXILSKFDQXZPP; [M+C4H6N2+H]+; Vinylethylnitrosamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -159.581; PZMXDLWWQHYXGY; [M+H]+; Oprea1_583437
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.154; OWSNZTOUPZXKPJ; [M+C4H6N2+H]+; Methylallylnitrosamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.889; ITDOBWWRWYKLQJ; [M+C2H3N+H]+; (2-Piperidylidene)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.220; CLMGCKCDSPUQEE; [M+C4H6N2+H]+; cyclopropylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.243; UAUSQEVPWPGBHG; [M+C4H6N2+H]+; 3-Aminocrotonamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.742; AFGWGIRVJYUUMY; [M+H]+; Ambcb5109422
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.662; CNQSLMMJABEBDE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.274; ZJULPBMTEMGRNC; [M+C4H6N2+H]+; 2-Methoxyimidazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.167; KKCWBKUOPJMUQV; [M+C4H6N2+H]+; 2-azetidinecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.221; KENWBTPXOITUBG; [M+C2H3N+H]+; [3-(5-methyl-1,3,4-oxadiazol-2-yl)propyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.761; KMUNXDCQPABTSC; [M+H]+; N,4-Diethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.798; YDDAGKSURVEMCI; [M+C2H3N+H]+; Acetamide, 2-diazo-N,N-diethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.089; YUTDFIMDLUJOJK; [M+C2H3N+H]+; N-methyl-1,6-diazabicyclo[3.1.0]hexane-5-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.670; QSRIMEJLSVTOCT; [M+H]+; 4-[2-(1,2,4-triazol-1-yl)ethyl]morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.172; JFYKIEHOOZWARC; [M+C4H6N2+H]+; Oprea1_824763
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -228.075; NDFXVDCXWFVBHJ; [M+H]+; 5-amino-1-tert-butylpyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -228.599; IVIGOAVSYQZAMR; [M+H]+; 4-Ethoxy-6-ethyl-N-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -231.207; YXAYZDNOWMFZLL; [M+C4H6N2+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.803; DZQDVYLUCQEKGH; [M+H]+; 4-Methoxy-N-methyl-6-propyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.349; VPQRCGYRFWYOEO; [M+C4H6N2+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.546; DZOWYKFQSIAYCW; [M+C4H6N2+H]+; 3,6-dihydro-2H-oxazin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.882; QIXFXNMDRJRTIJ; [M+C2H3N+H]+; 1-Hem-aminoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.260; CIECLHRLHFXCEF; [M+H]+; 2-ethyl-6-(propan-2-ylamino)-1H-1,3,5-triazin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.184; OMCUPXRCMTUDHI; [M+C4H6N2+H]+; Cyclopropanecarboxamidoxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -248.743; PIXPFRMNXPKTFS; [M+C4H6N2+H]+; 4-Methyl-oxazolidin-(2Z)-ylideneamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.922; APLFLTVZOUDTFG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.450; UEUMMYRZUZKMRI; [M+C2H3N+H]+; Ambap52883-26-8
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.348; ZHFKVNRMZIOKGZ; [M+C4H6N2+H]+; 2-Oxazolamine, 4,5-dihydro-5-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -274.278; WONCYNYJYMAVNA; [M+C2H3N+H]+; 2-Amino-5-tert-butyl-1,3,4-oxadiazol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -277.820; ZQISRDCJNBUVMM; [M+C2H3N+H]+; histidol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -279.269; DHXLEVPVBKFTTR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.709; CIZWSGSWDKEWQD; [M+C2H3N+H]+; 1-(2-methoxyethyl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -286.198; LURMHCWOXHNATM; [M+C2H3N+H]+; 1-(2-methoxyethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.912; DUCOZVHXTHIRIB; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.781; DJPLUEGVLBIDTL; [M+H]+; 2-Amino-4-dimethylaminoethoxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -309.523; IPLIJMUJLJBZDZ; [M+C2H3N+H]+; 3-amino-1-imidazolylpropan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -321.980; MIWXKXSYVQATIB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -415.176; AKKYYGMQUOASSM; [M+H]+; 1-(5-Methyl-3-pyrazolylcarbonyl)-2-isopropylhydrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.492; ITDOBWWRWYKLQJ; [M+C2H3N+H]+; (2-Piperidylidene)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.426; ANRUJJLGVODXIK; [M+H]+; Carcinine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.251; NQPJDJVGBDHCAD; [M+C4H6N2+H]+; Propyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -49.663; DQDBWHAMWLPFKF; [M+C4H6N2+H]+; N-(3-iminopropyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -57.754; PRKMPYVDQCMIJB; [M+C4H6N2+H]+; N-[(Z)-2-(methylamino)ethenyl]formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -59.899; RETKORUFJCYBGR; [M+C4H6N2+H]+; N-(prop-2-enylamino)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -60.030; TUQUPYWINZGJEQ; [M+C4H6N2+H]+; N-[(Z)-2-aminoprop-1-enyl]formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -60.316; MZTNSCOZNQDCAL; [M+C4H6N2+H]+; 2-(Aminomethyl)-3-iminopropanal
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -61.046; UHFLHAMUFVHWQQ; [M+C4H6N2+H]+; N-[(Z)-1-aminoprop-1-en-2-yl]formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -61.163; DLLBWQAUNAZAKX; [M+C4H6N2+H]+; N-(2-methyliminoethyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -61.260; OKPUKRLVPXHRJN; [M+C4H6N2+H]+; N-[(ethenylamino)methyl]formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -61.655; PXRRNVSZWJZBEH; [M+C4H6N2+H]+; N-[(Z)-2-aminoethenyl]-N-methylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -61.920; IMUGPOMSRPVMCL; [M+C4H6N2+H]+; N-(2-aminoprop-2-enyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -105.066; KAYNYFQEUPJJMT; [M+Na]+; [[tert-Butyl(tert-butoxy)amino]oxy]radical
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -110.616; NETSEJKXZLQGHX; [M+Na]+; [[1-(Butylamino)butyl]peroxy]radical
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -152.510; ANRUJJLGVODXIK; [M+H]+; Carcinine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -159.200; HAUMDMJMVPAREL; [M+Na]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -170.865; KENWBTPXOITUBG; [M+C2H3N+H]+; 3-(5-Methyl-1,3,4-oxadiazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -179.993; OZVXTNDTEWDMGH; [M+C2H3N+H]+; 2-amino-2-(1-methyl-1H-pyrazol-4-yl)ethan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.914; YDDAGKSURVEMCI; [M+C2H3N+H]+; (E)-2-(diethylamino)-2-hydroxyethenediazonium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -183.030; QSRIMEJLSVTOCT; [M+H]+; 4-(2-(1H-1,2,4-Triazol-1-yl)ethyl)morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -183.834; KMUNXDCQPABTSC; [M+H]+; N,4-Diethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -189.023; JMPBEKGLEKWBNL; [M+Na]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -189.205; REYGCAPKUGCICS; [M+C2H3N+H]+; N-[(3-Methyl-1,2,4-oxadiazol-5-YL)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -189.879; GNMSTEOVIGIVCR; [M+H]+; 1-(2-methoxyethyl)-1H,4H,5H,6H,7H-[1,2,3]triazolo[4,5-c]pyridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -200.898; AFGWGIRVJYUUMY; [M+H]+; 4-Ethoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -202.831; QIXFXNMDRJRTIJ; [M+C2H3N+H]+; 1-(2-Hydroxyethyl)-2-methyl-5-aminoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -206.811; NDFXVDCXWFVBHJ; [M+H]+; 5-amino-1-tert-butyl-1H-pyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -209.546; UEUMMYRZUZKMRI; [M+C2H3N+H]+; 4,5-Diethyl-2,4-dihydro-3H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.419; CIECLHRLHFXCEF; [M+H]+; 1,3,5-Triazin-2(1H)-one, 4-ethyl-6-((1-methylethyl)amino)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -213.091; VUQAASCCQZTWOG; [M+C2H3N+H]+; 5-Butan-2-yl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -213.901; YSSJLUSRTMOENN; [M+H]+; 2-(methoxymethyl)-5H,6H,7H,8H-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -217.955; ZQISRDCJNBUVMM; [M+C2H3N+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -222.869; LEWKFFUYRKWKLV; [M+C2H3N+H]+; 2-Isopropyl-5-methyl-2,4-dihydro-[1,2,4]triazol-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -225.117; ITDOBWWRWYKLQJ; [M+C2H3N+H]+; Urea, (3,4,5,6-tetrahydro-2-pyridinyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -242.772; IVIGOAVSYQZAMR; [M+H]+; 4-Ethoxy-6-ethyl-N-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -243.482; DZQDVYLUCQEKGH; [M+H]+; 1,3,5-Triazin-2-amine, 4-methoxy-N-methyl-6-propyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.294; ANRUJJLGVODXIK; [M+H]+; Carcinine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.141; DQDBWHAMWLPFKF; [M+C4H6N2+H]+; N-(3-iminopropyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.113; KENWBTPXOITUBG; [M+C2H3N+H]+; 3-(5-Methyl-1,3,4-oxadiazol-2-yl)propan-1-amine
COMMENT: CONFIDENCE Level 5: Exact mass of interest 183.124062; Observed in MS1; Charge state +1;
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.641
MS$FOCUSED_ION: PRECURSOR_M/Z 183.124062
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00lr-1900000000-e2a6dba5f87eb6c34bdc
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  69.0447344 56.1361 ? 69.045360 1.0138 12.19 0.6073 99
  71.0603068 42.7112 ? 71.060920 1.4213 6.12 0.6902 99
  72.0444035 114.8026 ? 72.045010 0.6107 13.29 0.7476 99
  85.0759408 25.9428 ? 85.076420 1.1049 6.58 0.6422 99
  87.0915869 32.7777 ? 87.092040 1.2516 8.40 0.3800 99
  97.0759850 14.0995 ? 97.076330 2.3178 4.13 0.3666 84
  98.9840900 33.4767 ? 98.984420 1.1618 28.22 0.0858 99
  112.0869654 47.4091 ? 112.087170 1.3829 12.26 0.5086 99
  113.0709664 283.5872 ? 113.071160 0.3891 26.44 0.9094 99
  115.0501892 22.6439 ? 115.050360 2.1730 6.92 0.3515 99
  115.0866196 608.5292 ? 115.086790 0.2867 57.97 0.8397 99
  123.0552807 16.2274 ? 123.055350 1.8203 4.63 0.3330 89
  124.0869049 41.4907 ? 124.086960 1.5151 9.08 0.6700 99
  125.0709086 24.3997 ? 125.070950 1.8949 6.83 0.3973 99
  127.0154464 29.7674 ? 127.015460 1.5116 23.63 -0.0197 99
  138.0661944 30.2203 ? 138.066100 1.1878 7.86 0.3927 99
  138.1025545 25.5217 ? 138.102460 1.6003 6.80 0.5192 99
  140.0818357 104.3815 ? 140.081740 0.7853 16.54 0.8565 99
  142.0974971 17.6465 ? 142.097400 1.6538 4.70 0.3625 91
  155.0466954 16.9688 ? 155.046590 2.5670 11.06 -0.2002 85
  155.0926255 23.0194 ? 155.092520 1.6506 6.62 0.2743 98
  165.1135119 53.3295 ? 165.113400 1.7866 8.51 0.7571 99
  166.0975225 47.1804 ? 166.097410 1.5774 7.00 0.7144 99
  183.0884433 64.5775 ? 183.088320 1.9444 17.79 0.4708 70
  183.1241433 999.0000 ? 183.124020 0.5188 0.00 1.0000 99
  183.1600333 188.3608 ? 183.159910 1.1029 27.63 0.7203 86
  183.1942634 81.3652 ? 183.194140 1.5393 23.88 -0.0776 97
PK$NUM_PEAK: 27
PK$PEAK: m/z int. rel.int.
  69.044734 56.14 56
  71.060307 42.71 42
  72.044403 114.80 114
  85.075941 25.94 25
  87.091587 32.78 32
  97.075985 14.10 14
  98.984090 33.48 33
  112.086965 47.41 47
  113.070966 283.59 283
  115.050189 22.64 22
  115.086620 608.53 608
  123.055281 16.23 16
  124.086905 41.49 41
  125.070909 24.40 24
  127.015446 29.77 29
  138.066194 30.22 30
  138.102554 25.52 25
  140.081836 104.38 104
  142.097497 17.65 17
  155.046695 16.97 16
  155.092625 23.02 23
  165.113512 53.33 53
  166.097523 47.18 47
  183.088443 64.58 64
  183.124143 999.00 999
  183.160033 188.36 188
  183.194263 81.37 81
//
